1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Needle-Free Devices, Technologies and Global Markets

Needle-Free Devices, Technologies and Global Markets

  • January 2015
  • 204 pages
  • ID: 2577354

Summary

Table of Contents

This BCC Research report covers the needle-free devices and technologies market, key growth areas, market strategy, product scope and quantitative market projections for technologies and devices. Market projections are provided through 2019.

Use this report to:
Estimate the market for needle-free devices and technologies, excluding the drug sales combined with these devices.

Receive information on needle-free injectors, Inhaler and transdermal patch technologies.

Identify promising new devices, materials and technologies still in the development and testing stage, and assess the probability that they will be commercialized successfully in the next five years.

Identify and evaluate the impact of demographic, economic and other factors that will drive future demand for needle-free devices and technologies market.

Highlights

The global market for needle free technologies reached $963.6 million in 2013. This market is expected to grow to $1.1 billion in 2014 and $2.1 billion in 2019, with a compound annual growth rate (CAGR) of 14.3%.

The U.S. market reached $531.6 million in 2013. This market is expected to grow to $607.4 million 2014 and $1.2 billion in 2019, with a CAGR of 14.8%.

The European market is expected to grow to $379.7 million in 2014 and $724.4 billion in 2019, with a CAGR of 13.8%.

INTRODUCTION

NEEDLE-FREE DEVICES

In recent years there has been a growing concern regarding needle-based drug delivery devices due to needle phobia, increasing cases of needlestick injuries and the transmission of blood-borne diseases. Needle-free drug delivery devices are considered as an effective alternative and novel technique to introduce drugs into a patient’s body without invading the skin with a needle. It is growing in popularity and has received considerable attention during the past few years primarily due to painless, effective and safe drug delivery methods. Needle-free drug delivery devices typically include needle-free injectors, inhalers, transdermal patches and other devices based on novel needle technologies (e.g., microneedles and advanced pen needles).

According to BCC Research estimates, the global market for needle-free drug delivery technologies (excluding drug sales) is estimated to be approximately $1 billion, whereas the market for pharmaceutical products combined with needle-free technology is estimated to be more than $25 billion. The needle-free injector segment is considered one of the fastest growing segments within the needle-free device and technology market. Key players within the market for needle-free drug delivery technologies include 3M, Consort Medical, PharmaJet, Ypsomed Holding, Zogenix, Antares Pharma and Bioject Medical Technologies.

STUDY BACKGROUND

Delivery of medicine and drugs to patients is typically done through pills, tablets or even in liquid form, either orally or using injection. Drug delivery is administered by injection (intravenously) when the drug must reach the systemic circulation quicker, or when the drug has a shorter half-life, often seen during emergencies. In addition, there are a large number of therapies, particularly protein, gene and vaccine-based medications, that cannot be delivered orally and require intravenous delivery.

The goal of modern needle-free drug delivery techniques is to increase the prescribing and adoption of important drugs that require self-injection, such as biologics.
Continuous innovation and availability of newer needle-free drug delivery systems have the potential to be enabling for highly viscous drug products that cannot be delivered by the traditional needle and syringe, adding to the utility of the technology.
As more companies begin to recognize the benefits, needle-free injection technology will continue to grow in popularity, both among patients and physicians, and ultimately increase adoption of injectable drug therapies.

This report is the first edition of in-depth report to cover the needle-free devices and technologies market, key growth areas, market strategy, product scope and quantitative market projections for technologies and devices. This report includes detailed market size and analysis of needle-free drug delivery devices, including needle-free jet injectors, inhalers, transdermal patch and other novel needle technologies (e.g., microneedles and advanced pen needles). In addition, it includes qualitative and quantitative factors that are driving the global needle-free devices and technologies market. This study attempts to give the reader the information and analysis they need to deal with these challenges.

STUDY GOALS AND OBJECTIVES

During the past several decades, tremendous progress has been made toward the development of safe, effective and convenient means of drug administration. Advances have been possible, at least in part, because of increasing awareness about health concerns associated with traditional needle-based drug delivery devices and
technological innovations to meet the current challenges.

This study, Needle-Free Devices, Technologies and Global Markets, provides an overview of products included in this market and detailed analyses of markets and competitive environments.

This report focuses on some key developments in the field of drug delivery, especially those that deal with the development of painless, patient-friendly alternatives to injections for the delivery of macromolecules. This area covers a wide variety of products that help in safe and effective drug delivery. The study includes information
about significant products, players, issues and trends, and other information affecting the needle-free drug delivery industry.

Our study meets these needs by analyzing global markets for needle-free devices and technologies (see the section “Scope” for a definition of these) in light of the most recently available information. In addition to looking at current and future markets, the study will analyze technological, demographic and economic developments that may have a long-term impact on the size and structure of the needle-free devices and
technologies market. The future of needle-free technology will also be discussed with the market forecasts.

More specific objectives are to:

Identify and segment the needle-free drug delivery market by technology and applications.
Estimate the market for needle-free devices and technologies, excluding the drug sales combined with these devices.
Analyze the type of needle-free drug delivery devices and technologies by geographic markets.
Identify and evaluate the impact of demographic, economic and other factors that will drive future demand for needle-free devices and technologies market.
Forecast the various needle-free technologies that are used for various drug delivery applications.
Identify promising new devices, materials and technologies still in the development and testing stage, and assess the probability that they will be commercialized successfully in the next five years.
Forecast the potential market based on the pipeline, taking into account the estimated probability that they will be commercialized.
Identify leading device manufacturers, technology suppliers and pharmaceutical partners to analyze the structure of the needle-free devices and technologies market within drug delivery industry (e.g., market shares, concentration, and recent merger and acquisition activity)
Assess the long-term outlook for the needle-free drug delivery devices and technologies market, taking into account market opportunities, as well as technological, financial and economic factors.
This study will provide the reader with the knowledge to adequately view and assess the market for needle-free drug delivery devices and technologies while gaining insight into the market’s potential.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Amniocentesis Needle Market by Type, Procedure, End User - Global Forecast to 2022

Amniocentesis Needle Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

Global amniocentesis needles market projected to grow at a CAGR of 2.8% during the forecast periodThe amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 150.6 million ...

Global Intravenous Access Devices Market 2017-2021

Intravenous Access Devices Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • December 2017
  • by Infiniti Research Limited

About Intravenous Access DevicesIntravenous access devices can be inserted into peripheral or central veins for the administration of fluids and nutritional compounds (hyperalimentation); delivery of medications ...

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • October 2017
  • by GlobalData

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017" ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.